Similar mental disorders have also been observed in healthy volunteers and mice peripherally administered IFN-α [12–14], and abnormal levels of IFN-α in the sera and cerebrospinal fluid (CSF) of patients have been observed [15, 16], supporting the direct interaction between IFN-α and behavioural symptoms. The gene discussed is IFNA1; the disease is psychiatric disorder.